Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-04-08Clinical Trial Update: Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B
Clinical trial update on withdrawing antiviral therapy after long-term treatment for chronic hepatitis B; the study status is completed.
-
CLINICAL_TRIALS withdrawal · 2025-12-26Clinical Trial Update: Study of ARC-520 in Patient With Chronic Hepatitis B Virus [Phase 2]
A Phase 2 study of ARC-520 for chronic hepatitis B has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-08-03Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of TQA3605 Tablets in Treatment-naive Chronic HBV-infected Subjects [Phase 2]
A Phase 2 trial evaluating TQA3605 tablets for treatment-naive chronic hepatitis B was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-06-25Clinical Trial Update: A Study in Chronic Hepatitis B e-Antigen Negative Participants After Discontinuation of Nucleos(t)Ide Analog (NA) Treatment [EARLY_Phase 1]
An early-phase 1 study evaluating discontinuation of nucleos(t)ide analog therapy in e-antigen negative chronic hepatitis B participants has…
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma) [Phase 3]
Phase 3 trial evaluating a pentavalent DTP-HB-Hib vaccine for immunogenicity and safety has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA withdrawal · 2025-01-10EMA Withdrawn: PreHevbri (hepatitis B surface antigen) — VBI Vaccines B.V.
The EMA has withdrawn the marketing authorization for PreHevbri (hepatitis B surface antigen) from VBI Vaccines B.V.
-
CLINICAL_TRIALS withdrawal · 2024-10-15Clinical Trial Update: Study of IMC-I109V in Non-cirrhotic HBeAg-negative Chronic HBV Infection [Phase 1]
The Phase 1 trial of IMC-I109V for non-cirrhotic, HBeAg-negative chronic hepatitis B infection has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-08-12Clinical Trial Update: Study of Imdusiran (AB-729) in Combination With Intermittent Dosing of Durvalumab in Subjects With Chronic HBV Infection [Phase 2]
A Phase 2 study evaluating Imdusiran (AB-729) with intermittent Durvalumab dosing in chronic hepatitis B subjects has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-08-06Clinical Trial Update: Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates [Phase 2]
A Phase 2 study evaluating the use of hepatitis B virus NAT-positive donors for hepatitis B-vaccinated lung transplant candidates has been w…
-
CLINICAL_TRIALS withdrawal · 2024-07-11Clinical Trial Update: Evaluation of the Effectiveness of the Complex of Carnitine Orotate and Biphenyl Dimethyl Dicarboxylate in the Adjuvant Therapy of Chronic Hepatitis D in Real Clinical Practice: a Prospective Cohort Study
A real-world prospective cohort trial evaluating the effectiveness of a complex of carnitine orotate and biphenyl dimethyl dicarboxylate for…
-
EMA withdrawal · 2023-03-06EMA Withdrawn: Hepsera (adefovir dipivoxil) — Gilead Sciences Ireland UC
Hepsera (adefovir dipivoxil) has been withdrawn from the European market for chronic hepatitis B.
-
EMA withdrawal · 2021-01-14EMA Withdrawn: Sebivo (telbivudine) — Novartis Europharm Limited
Withdrawal of Sebivo (telbivudine) from the market by Novartis Europharm Limited for chronic hepatitis B.
-
CLINICAL_TRIALS withdrawal · 2020-06-01Clinical Trial Update: Combination Hepatitis A and B Vaccine to Induce Immunity in Non-responders [Phase 4]
A Phase 4 trial evaluating a combination Hepatitis A and B vaccine in non-responders has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-07-24Clinical Trial Update: A Nationwide Epidemiological, Educational Support Program for Improving Treatment Adherence in Patients With HBV
The study evaluating a nationwide epidemiological and educational support program to improve hepatitis B treatment adherence has been withdr…
-
CLINICAL_TRIALS withdrawal · 2017-10-16Clinical Trial Update: A Study Evaluating AL-3778 in Combination With Peginterferon Alpha-2a in Chronic Hepatitis B Subjects [Phase 2]
A Phase 2 trial evaluating AL-3778 in combination with peginterferon alpha-2a for chronic hepatitis B has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-03-06Clinical Trial Update: Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα [Phase 3]
A Phase 3 trial evaluating antiviral prophylaxis for HBsAg-positive or HBcAb-positive/HBsAb-negative patients starting anti-TNF therapy has …
-
CLINICAL_TRIALS withdrawal · 2017-02-17Clinical Trial Update: A Study of 48 Versus 96 Weeks of Peginterferon Alfa-2a [Pegasys] Treatment, With or Without Entecavir, in Patients With Chronic Hepatitis B. [Phase 4]
A Phase 4 trial evaluating 48 vs 96 weeks of Pegasys (peginterferon alfa-2a) with or without entecavir in chronic hepatitis B was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-10-18Clinical Trial Update: Comparison Between Lamivudine and Entecavir Treatment in Spontaneous Severe Acute Exacerbation [Phase 4]
A Phase 4 trial comparing lamivudine and entecavir for spontaneous severe acute exacerbation in chronic hepatitis B has been terminated.
-
CLINICAL_TRIALS withdrawal · 2016-09-23Clinical Trial Update: Efficacy of Telbivudine in Blacks/African Americans and Hispanics/Latinos With Compensated Chronic Hepatitis B During 52 Weeks [Phase 4]
A Phase 4 trial evaluating telbivudine in Black/African American and Hispanic/Latino patients with compensated chronic hepatitis B was withd…
-
CLINICAL_TRIALS withdrawal · 2016-09-21Clinical Trial Update: Entecavir for Subjects With Chronic Hepatitis B Infection: An Early Access Program
Entecavir's Early Access Program for chronic hepatitis B has ended and is no longer available.
-
CLINICAL_TRIALS withdrawal · 2016-07-28Clinical Trial Update: Effect of Telbivudine on Renal Function and Proteinuria in Patients With CHB & Chronic Renal Diseases [NA]
The clinical trial NCT02049736 evaluating telbivudine for renal function and proteinuria in chronic hepatitis B patients with chronic kidney…
-
CLINICAL_TRIALS withdrawal · 2016-02-22Clinical Trial Update: Chronic Hepatitis B and C Recall Northern Holland
A clinical trial in Northern Holland involving Hepatitis B and Hepatitis C is being recalled/withdrawn; status is currently UNKNOWN.
-
CLINICAL_TRIALS withdrawal · 2016-01-18Clinical Trial Update: Nabi-HB Administered Subcutaneously in Patients With Hepatitis B Virus Post Liver Transplantation [Phase 3]
Phase 3 trial of Nabi-HB given subcutaneously for chronic hepatitis B after liver transplantation has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-11-18Clinical Trial Update: Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084) [Phase 4]
This Phase 4 study evaluating long-term hepatitis A and B antibody persistence in healthy adults previously primed with Twinrix has been wit…
-
CLINICAL_TRIALS withdrawal · 2015-09-01Clinical Trial Update: Entecavir Plus Adefovir in Lamivudine-Resistant Patients [Phase 4]
A Phase 4 trial evaluating the combination of entecavir and adefovir for lamivudine-resistant chronic hepatitis B has been withdrawn.